Page 75 - AN-3-2
P. 75
Advanced Neurology Inflammation in diabetic stroke: Treatment target
99. Westendorp WF, Vermeij JD, Smith CJ, et al. Preventive 2015;35(5):2133-2145.
antibiotic therapy in acute stroke patients: A systematic doi: 10.1523/JNEUROSCI.4098-14.2015
review and meta-analysis of individual patient data of
randomized controlled trials. Eur Stroke J. 2021;6(4):385-394. 110. Thapa R, Afzal O, Alfawaz Altamimi AS, et al. Galangin
as an inflammatory response modulator: An updated
doi: 10.1177/23969873211056445 overview and therapeutic potential. Chem Biol Interact.
100. Wen H, Weymann KB, Wood L, Wang QM. Inflammatory 2023;378:110482.
signaling in post-stroke fatigue and depression. Eur Neurol. doi: 10.1016/j.cbi.2023.110482
2018;80(3-4):138-148.
111. Xu H, Wang E, Chen F, Xiao J, Wang M. Neuroprotective
doi: 10.1159/000494988 phytochemicals in experimental ischemic stroke:
101. Caiaffo V, Oliveira BD, de Sa FB, Evencio Neto J. Anti- Mechanisms and potential clinical applications. Oxid Med
inflammatory, antiapoptotic, and antioxidant activity of Cell Longev. 2021;2021:6687386.
fluoxetine. Pharmacol Res Perspect. 2016;4(3):e00231. doi: 10.1155/2021/6687386
doi: 10.1002/prp2.231 112. Zhu T, Wang L, Feng Y, Sun G, Sun X. Classical active
102. Schneider CL, Prentiss EK, Busza A, Williams ZR, ingredients and extracts of Chinese herbal medicines:
Mahon BZ, Sahin B. FLUORESCE: A pilot randomized Pharmacokinetics, pharmacodynamics, and molecular
clinical trial of fluoxetine for vision recovery after acute mechanisms for ischemic stroke. Oxid Med Cell Longev.
ischemic stroke. J Neuroophthalmol. 2023;43(2):237-242. 2021;2021:8868941.
doi: 10.1097/WNO.0000000000001654 doi: 10.1155/2021/8868941
103. Knox MG, Demaerschalk BM, Alcott SB, Marks LA, 113. Zhou P, Du S, Zhou L, et al. Tetramethylpyrazine2’Osodium
Wingerchuk DM, O’Carroll CB. Does the initiation of fluoxetine ferulate provides neuroprotection against
postacute stroke result in improved functional recovery?: neuroinflammation and brain injury in MCAO/R rats
A critically appraised topic. Neurologist. 2021;26(3):112-115. by suppressing TLR-4/NF-kappaB signaling pathway.
Pharmacol Biochem Behav. 2019;176:33-42.
doi: 10.1097/NRL.0000000000000314
doi: 10.1016/j.pbb.2018.08.010
104. Li N, Hua J. Interactions between mesenchymal
stem cells and the immune system. Cell Mol Life Sci. 114. Tsai FJ, Ho TJ, Cheng CF, et al. Effect of Chinese herbal
2017;74(13):2345-2360. medicine on stroke patients with type 2 diabetes.
J Ethnopharmacol. 2017;200:31-44.
doi: 10.1007/s00018-017-2473-5
doi: 10.1016/j.jep.2017.02.024
105. He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative
stress, inflammation, and autophagy: Potential targets of 115. Ritzel RM, Lai YJ, Crapser JD, et al. Aging alters the
mesenchymal stem cells-based therapies in ischemic stroke. immunological response to ischemic stroke. Acta
Front Neurosci. 2021;15:641157. Neuropathol. 2018;136(1):89-110.
doi: 10.3389/fnins.2021.641157 doi: 10.1007/s00401-018-1859-2
106. Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal 116. Buga AM, Di Napoli M, Popa-Wagner A. Preclinical models
stem cell therapy for ischemic stroke: A look into of stroke in aged animals with or without comorbidities: Role
treatment mechanism and therapeutic potential. J Neurol. of neuroinflammation. Biogerontology. 2013;14(6):651-662.
2021;268(11):4095-4107. doi: 10.1007/s10522-013-9465-0
doi: 10.1007/s00415-020-10138-5 117. Yamashiro K, Kurita N, Urabe T, Hattori N. Role
107. Cordeau P Jr., Lalancette-Hebert M, Weng YC, Kriz J. Live of the gut microbiota in stroke pathogenesis and
imaging of neuroinflammation reveals sex and estrogen potential therapeutic implications. Ann Nutr Metab.
effects on astrocyte response to ischemic injury. Stroke. 2021;77 Suppl 2(Suppl 2):36-44.
2008;39(3):935-942. doi: 10.1159/000516398
doi: 10.1161/STROKEAHA.107.501460 118. Delrue C, Delanghe JR, Speeckaert MM. The role of sRAGE
108. Chernykh ER, Shevela EY, Starostina NM, et al. Safety in cardiovascular diseases. Adv Clin Chem. 2023;117:53-102.
and therapeutic potential of M2 macrophages in stroke doi: 10.1016/bs.acc.2023.08.005
treatment. Cell Transplant. 2016;25(8):1461-1471.
119. Baker EW, Kinder HA, West FD. Neural stem cell therapy
doi: 10.3727/096368915X690279 for stroke: A multimechanistic approach to restoring
neurological function. Brain Behav. 2019;9(3):e01214.
109. Doyle KP, Quach LN, Sole M, et al. B-lymphocyte-mediated
delayed cognitive impairment following stroke. J Neurosci. doi: 10.1002/brb3.1214
Volume 3 Issue 2 (2024) 14 doi: 10.36922/an.1694

